C.N. Chesterman

3.6k total citations · 1 hit paper
40 papers, 2.6k citations indexed

About

C.N. Chesterman is a scholar working on Hematology, Molecular Biology and Internal Medicine. According to data from OpenAlex, C.N. Chesterman has authored 40 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 9 papers in Molecular Biology and 8 papers in Internal Medicine. Recurrent topics in C.N. Chesterman's work include Platelet Disorders and Treatments (12 papers), Venous Thromboembolism Diagnosis and Management (8 papers) and Protease and Inhibitor Mechanisms (7 papers). C.N. Chesterman is often cited by papers focused on Platelet Disorders and Treatments (12 papers), Venous Thromboembolism Diagnosis and Management (8 papers) and Protease and Inhibitor Mechanisms (7 papers). C.N. Chesterman collaborates with scholars based in Australia, United Kingdom and United States. C.N. Chesterman's co-authors include H. Patrick McNeil, Steven A. Krilis, Richard J. Simpson, Beng H. Chong, Levon M. Khachigian, D. Owensby, Philip J. Hogg, Michael C. Berndt, Michael P. Skinner and Gordon F. Burns and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

C.N. Chesterman

39 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H).

1990 1.3k citations H. Patrick McNeil, Richard J. Simpson et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C.N. Chesterman Australia	22	1.3k	1000	576	467	459	40	2.6k
S. Loizou United Kingdom	24	2.8k 2.1×	1.2k 1.2×	870 1.5×	733 1.6×	192 0.4×	43	3.5k
Thomas Exner Australia	26	1.0k 0.8×	1.0k 1.0×	360 0.6×	324 0.7×	349 0.8×	82	2.3k
Robert Roubey United States	29	2.3k 1.8×	1.2k 1.2×	748 1.3×	1.3k 2.7×	362 0.8×	62	3.4k
Olga Amengual Japan	28	2.0k 1.5×	1.2k 1.2×	386 0.7×	648 1.4×	201 0.4×	90	2.6k
P G de Groot Netherlands	22	710 0.5×	794 0.8×	109 0.2×	240 0.5×	208 0.5×	34	1.8k
Shinsuke Yasuda Japan	32	1.8k 1.4×	1.1k 1.1×	251 0.4×	993 2.1×	474 1.0×	163	3.2k
Carrie Wagner United States	33	1.9k 1.5×	936 0.9×	714 1.2×	1.8k 3.9×	538 1.2×	53	4.8k
Cecilia Beatrice Chighizola Italy	27	1.7k 1.3×	884 0.9×	226 0.4×	610 1.3×	159 0.3×	90	2.5k
Heikki Julkunen Finland	29	1.8k 1.4×	327 0.3×	361 0.6×	1.1k 2.4×	218 0.5×	88	2.6k
Geoffrey F. Savidge United Kingdom	31	207 0.2×	1.6k 1.6×	114 0.2×	227 0.5×	464 1.0×	97	2.8k

Countries citing papers authored by C.N. Chesterman

Since Specialization

Citations

This map shows the geographic impact of C.N. Chesterman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C.N. Chesterman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C.N. Chesterman more than expected).

Fields of papers citing papers by C.N. Chesterman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C.N. Chesterman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C.N. Chesterman. The network helps show where C.N. Chesterman may publish in the future.

Co-authorship network of co-authors of C.N. Chesterman

This figure shows the co-authorship network connecting the top 25 collaborators of C.N. Chesterman. A scholar is included among the top collaborators of C.N. Chesterman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C.N. Chesterman. C.N. Chesterman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chong, Beng H., J. F. Cade, Harry Magnani, et al.. (2001). Prospective Randomised Open-label Comparison of Danaparoid with Dextran 70 in the Treatment of Heparin-induced Thrombocytopaenia with Thrombosis. Thrombosis and Haemostasis. 86(11). 1170–1175. 106 indexed citations

Brighton, Timothy & C.N. Chesterman. (2000). The clinical significance of antiphospholipid antibodies in patients without autoimmune disease. Australian and New Zealand Journal of Medicine. 30(6). 693–703.

Chesterman, C.N., et al.. (2000). Reduction of von Willebrand Factor by Endothelial Cells. Thrombosis and Haemostasis. 84(9). 506–513. 33 indexed citations

Whitworth, Judith A., et al.. (1995). Effects of cyclosporin A and dexamethasone on haemostatic and vasoactive functions of vascular endothelial cells. Blood Coagulation & Fibrinolysis. 6(5). 438–445. 41 indexed citations

Hicks, C., M.J. Sleigh, & C.N. Chesterman. (1994). Quantitation of platelet derived growth factor receptors on cells from human arterial segments. Journal of Immunological Methods. 170(1). 83–92. 6 indexed citations

Markovic, Boban, Zhanhe Wu, C.N. Chesterman, & Beng H. Chong. (1994). Quantitation of FcγRII mRNA in platelets and megakaryoblastic cell lines by a new method of in situ hybridization. Journal of Immunological Methods. 172(1). 105–114. 21 indexed citations

Khachigian, Levon M. & C.N. Chesterman. (1993). Platelet-derived Growth Factor and its Receptor: Structure and Roles in Normal Growth and Pathology. Platelets. 4(6). 304–315. 10 indexed citations

Chesterman, C.N., et al.. (1993). Clinical analysis of 125 patients with the lupus anticoagulant. Australian and New Zealand Journal of Medicine. 23(2). 151–156. 20 indexed citations

Skinner, Michael P., Claire Lucas, Gordon F. Burns, C.N. Chesterman, & Michael C. Berndt. (1991). GMP-140 binding to neutrophils is inhibited by sulfated glycans.. Journal of Biological Chemistry. 266(9). 5371–5374. 173 indexed citations

10.

Shi, Wendan, SA Krilis, Beng H. Chong, S. Gordon, & C.N. Chesterman. (1990). Prevalence of lupus anticoagulant and anticardiolipin antibodies in a healthy population. Australian and New Zealand Journal of Medicine. 20(3). 231–236. 153 indexed citations

11.

McNeil, H. Patrick, Richard J. Simpson, C.N. Chesterman, & Steven A. Krilis. (1990). Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H).. Proceedings of the National Academy of Sciences. 87(11). 4120–4124. 1299 indexed citations breakdown →

12.

Chesterman, C.N.. (1988). Vascular endothelium, haemostasis and thrombosis. Blood Reviews. 2(2). 88–94. 35 indexed citations

13.

McNeil, H. Patrick, C.N. Chesterman, & Steven A. Krilis. (1988). Binding specificity of lupus anticoagulants and anticardiolipin antibodies. Thrombosis Research. 52(6). 609–619. 25 indexed citations

14.

Chesterman, C.N., et al.. (1986). Substrate for endothelial prostacyclin production in the presence of platelets exposed to collagen is derived from the platelets rather than the endothelium. Blood. 67(6). 1744–1750. 24 indexed citations

15.

Morgan, Francis J., Geoffrey S. Begg, & C.N. Chesterman. (1977). Primary Structure of Human Platelet Factor 4.. Thrombosis and Haemostasis. 9 indexed citations

16.

Chesterman, C.N., S.A. Cederholm-Williams, M.J. Allington, & A. A. Sharp. (1977). The formation of a fibrinogen-activator complex by the action of streptokinase. Thrombosis Research. 10(3). 421–430. 9 indexed citations

17.

Tibbutt, David & C.N. Chesterman. (1976). Pulmonary Embolism. Drugs. 11(3). 161–192. 17 indexed citations

18.

Gaffney, Patrick J., C.N. Chesterman, & M.J. Allington. (1974). Plasma Fibrinogen and its Fragments during Streptokinase Treatment. British Journal of Haematology. 26(2). 285–293. 23 indexed citations

19.

Chan, Tuen‐Ching, C.N. Chesterman, A. J. S. McFadzean, & D. Todd. (1971). The survival of glucose-6-phosphate dehydrogenase--deficient erythrocytes in patients with typhoid fever on chloramphenicol therapy.. PubMed. 77(2). 177–84. 15 indexed citations

20.

Chesterman, C.N., J. C. Biggs, John P. Morgan, & J. B. Hickie. (1969). STREPTOKINASE THERAPY IN ACUTE MAJOR PULMONARY EMBOLISM. The Medical Journal of Australia. 2(22). 1096–1100. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact